Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
279 studies found for:    Raltegravir OR Isentress[TREATMENT] AND HIV [CONDITION]
Show Display Options
Download search resultsDownload the search results for:
Raltegravir OR Isentress[TREATMENT] AND HIV [CONDITION] (279 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients
Conditions: HIV Infection;   Liver Failure;   Evidence of Liver Transplantation
Intervention: Drug: Raltegravir potassium
2 Active, not recruiting A Study to Assess the Efficacy of Raltegravir, Administered in Combination With Other Antiretroviral Drugs as Treatment for Adults and Older Adults Infected With the Human Immunodeficiency Virus 1 (HIV-1)(MK-0518-145) (Wirksamkeit Von Isentress® Unter Praxisbedingungen)
Condition: HIV-1 Infection
Intervention: Drug: Raltegravir
3 Completed Pharmacokinetic Study of the HCV Protease Inhibitor Boceprevir and the HIV Integrase Inhibitor Raltegravir
Conditions: HIV Infections;   HCV Infections
Interventions: Drug: boceprevir;   Drug: raltegravir
4 Completed
Has Results
Buprenorphine/Raltegravir Pharmacokinetic Interaction Study
Conditions: HIV Infection;   HIV Infections
Intervention: Drug: Raltegravir
5 Terminated
Has Results
A Study of the Neurological Effects of Adding Raltegravir to HAART Regimen in Patients With HIV
Conditions: Human Immunodeficiency Virus (HIV);   HIV Associated Neurocognitive Disorders (HAND)
Intervention: Drug: Raltegravir
6 Completed Raltegravir Use as Nonoccupational Postexposure Prophylaxis (NPEP) in Men Who Have Sex With Men
Conditions: HIV Prevention;   HIV Infections
Intervention: Drug: Raltegravir
7 Recruiting Evaluation of Raltegravir During the Third Trimester of Pregnancy
Conditions: HIV-1 Infection;   PREGNANCY
Intervention: Other: Study of pharmacokinetic properties of raltegravir during the 3rd trimester of pregnancy
8 Completed
Has Results
Antiretroviral Therapy Intensification With Raltegravir or Addition of Hyper-immune Bovine Colostrum in HIV-1 Infected Patients With Suboptimal CD4+ T Cell Response
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Hyper-immune Bovine Colostrum;   Other: raltegravir placebo;   Other: Hyper-immune Bovine Colostrum placebo;   Drug: raltegravir and hyper-immune bovine colostrum
9 Completed Effect of Antacids on the Pharmacokinetics of Raltegravir
Condition: HIV Infections
Interventions: Drug: raltegravir;   Drug: antacid
10 Completed
Has Results
Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: ARV (non-raltegravir)
11 Completed
Has Results
Atripla to Raltegravir Switch Study for CNS Toxicity
Condition: HIV Infection
Intervention: Drug: Truvada/Raltegravir
12 Completed Raltegravir and Atazanavir Dosing Strategy Study
Condition: HIV Infection
Intervention: Drug: atazanavir plus raltegravir
13 Completed Raltegravir Switch for Toxicity or Adverse Events
Conditions: HIV/AIDS;   Antiretroviral Therapy;   HIV Infections
Interventions: Drug: tenofovir emtricitabine raltegravir;   Drug: Lamivudine Abacavir Raltegravir;   Drug: Abacavir free
14 Completed Pharmacokinetic Drug Interaction Study Between Raltegravir and Atorvastatin.
Conditions: HIV;   Hypercholesterolaemia
Interventions: Drug: raltegravir;   Drug: Atorvastatin
15 Completed The Influence of GINkGo Biloba on the Pharmacokinetics of the UGT Substrate raltEgraviR (GINGER)
Conditions: HIV Infections;   Depression;   Mild Cognitive Impairment
Interventions: Drug: raltegravir single dose;   Drug: ginkgo biloba multiple dose
16 Active, not recruiting A Retrospective Analysis of Raltegravir Use in Minority HIV Infected Women in Houston, Texas
Condition: HIV Infection
Intervention: Drug: raltegravir
17 Completed Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients
Conditions: HIV Infection;   HIV Infections
Interventions: Drug: raltegravir QD;   Drug: atazanavir;   Drug: lamivudine (or emtricitabine)
18 Completed
Has Results
Levels of Raltegravir in the Female Genital Tissue
Condition: HIV
Intervention: Drug: Raltegravir
19 Completed Raltegravir as Early Therapy in African-Americans Living With HIV Study
Condition: HIV Infections
Intervention: Drug: Raltegravir + Truvada
20 Completed Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected Subjects
Condition: HIV Infections
Intervention: Drug: Raltegravir plus Darunavir/ritonavir

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years